000			05133cam a2200457Ii 4500
999			_c95045 _d95045 _x1
001			95045
003			ES-MaUEC
005			20230102112644.0
006			m o d
007			cr cnu|||unuuu
008			161216s2017 si o 000 0 eng d
020			_a9789811029295 _q(electronic bk.)
020			_a9811029296 _q(electronic bk.)
020			_z9789811029288
020			_z9811029288
035			_a(OCoLC)966313039 _z(OCoLC)966551741 _z(OCoLC)974650155 _z(OCoLC)981089868 _z(OCoLC)1005774083 _z(OCoLC)1011959674
040			_aN$T _cN$T _dGW5XE _dIDEBK _dEBLCP _dYDX _dOCLCF _dN$T _dAZU _dUAB _dCOO _dMERUC _dUPM _dIOG _dVT2 _dESU _dJBG _dIAD _dICW _dICN _dOTZ _dOCLCQ _dU3W _dES-MaUEC _bspa
050		4	_aQH588.S83 _bB664 2017 EB
245	0	0	_aBone marrow stem cell therapy for stroke _cKunlin Jin, Xunming Ji, Qichuan Zhuge, editors.
264		1	_aSingapore _bSpringer _c2017
300			_a1 recurso en línea
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF _2rda
500			_aSpringerLink
505	0		_aDedication; Preface; Contents; Contributors; Chapter 1: Ischemic Stroke Pathophysiology and Cell Therapy; 1.1 Introduction; 1.2 Pathophysiology of Ischemic Stroke; 1.2.1 Thrombosis; 1.2.2 Embolism; 1.2.3 Systemic Hypoperfusion; 1.2.4 Cellular Pathophysiology; 1.2.5 Cell Death After Stroke; 1.2.6 Mechanisms of Necrotic Cell Death; 1.2.7 Mechanisms of Programmed Cell Death; 1.3 Types of Stem Cells Used in Experimental Ischemic Stroke Therapy; 1.3.1 Embryonic Stem Cells (ESCs); 1.3.2 Mesenchymal Stem Cells (MSCs); 1.3.3 Bone Marrow-Derived MSCs (BMSCs).
505	8		_a1.3.4 Adipose-Derived Mesenchymal Stem Cells (AD-MSCs)1.3.5 Placenta-Derived Mesenchymal Stem Cells (PD-MSCs); 1.3.6 Induced Pluripotent Stem Cells (iPSCs); 1.3.6.1 Cell Therapy Using iPSCs for Stroke; 1.3.6.2 Mechanism of iPSC Therapy in Stroke; 1.3.7 Endothelial Progenitor Cells (EPCs); 1.3.7.1 Mechanism of EPC Therapy in Stroke; 1.3.8 Neural Stem Cells; 1.3.8.1 The Attempts to Treat Stroke with NSCs; 1.3.8.2 Underlying Mechanisms; References; Chapter 2: Bone Marrow Stem Cells: Source, Characterization, Isolation, Culture, and Identification; 2.1 Introduction; 2.2 Source.
505	8		_a2.2.1 Mesenchymal Stem Cells2.2.2 Hematopoietic Stem Cells; 2.2.3 Endothelial Progenitor Cells; 2.3 Characterization and Identification; 2.3.1 MSCs; 2.3.1.1 Morphology and Cell Cycle Study; 2.3.1.2 Differentiation Capacity; 2.3.1.3 Function; 2.3.1.4 Phenotype and Identification; 2.3.2 HSCs; 2.3.2.1 Multipotency; 2.3.2.2 Self-Renewal; 2.3.2.3 Markers and Identification; 2.3.3 EPCs; 2.3.3.1 Regenerative Potential of EPCs; 2.3.3.2 Phenotype and Identification; 2.4 Isolation; 2.4.1 MSCs; 2.4.2 HSCs; 2.4.3 EPCs; 2.5 Culture; 2.5.1 MSCs; 2.5.2 EPCs; 2.6 Conclusion; References.
505	8		_a3.3.2.1 Mechanisms of HSPC Mobilization After Stroke3.3.2.1.1 The SDF-1/CXCR4 Interaction; 3.3.2.1.2 Interplays of the Sympathetic Nervous System with SDF-1/CXCR4 and G-CSF; 3.3.2.2 Agents That Enhance the Mobilization of HSCs for Stroke; 3.3.3 HSC Homing to the Ischemic Brain; 3.3.3.1 Mechanisms of HSC Homing After Stroke; 3.3.3.2 Methods of Enhancing HSC Homing to Ischemic Brain; 3.3.4 Regulations of HSC on Neural Restoration and Neural Function After Stroke; 3.4 Bone Marrow-Derived Endothelial Progenitor Cells; 3.4.1 Characteristics of EPCs; 3.4.1.1 EPCs and Angiogenesis.
505	8		_aChapter 3: Mobilization and Homing of Bone Marrow Stem Cells After Stroke3.1 Introduction; 3.2 Bone Mesenchymal Stem Cells; 3.2.1 The Characterization of BMSCs; 3.2.2 BMSC Mobilization After Stroke; 3.2.3 The Potential Signaling Pathway/Mechanisms Underlying BMSC Homing; 3.2.3.1 MCP-1; 3.2.3.2 CD44 and Selectin; 3.2.4 BMSCs Induced Neurotrophic Factor Secretion and Restoration of Neural Function; 3.3 Bone Marrow-Derived Hematopoietic Stem Cells; 3.3.1 The Characterization of HSCs and the Niches; 3.3.1.1 The Characterization of HSCs; 3.3.1.2 The HSC Niches; 3.3.2 HSC Mobilization After Stroke.
520	3		_aThis book covers recent advances in all aspects of bone marrow-derived stem cells (BMSCs) for stroke treatment, while also providing comprehensive information on human clinical trials and animal models of stroke. In addition, it reviews the optimal conditions of transplantation for stroke therapy and potential mechanisms underlying transplanted cell-mediated functional recovery after stroke. As the first book to focus on BMSC therapy for stroke, it also discusses in depth the unique challenges of BMSCs-based therapy in this context.
988			_aEBOOK, asignarmaterias, EBSPRINGER_2017B
650		7	_2embne _aCélulas madre _9160528
700	1		_aJi, Xunming, _eeditor literario
700	1		_aJin, Kunlin, _eeditor literario
700	1		_aZhuge, Qichuan, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-981-10-2929-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI